Results 211 to 220 of about 62,929 (228)

Integrating Oxaliplatin with Highly Luminescent Carbon Dots: An Unprecedented Theranostic Agent for Personalized Medicine

Advanced Materials, 2014
Min Zheng, Shi Liu, Dan Qu
exaly  

Oxaliplatin: A Review in the Era of Molecularly Targeted Therapy

Current Oncology, 2011
Thierry Alcindor, Alcindor Thierry
exaly  

Oxaliplatin

Reactions Weekly
openaire   +2 more sources

Oxaliplatin

Reactions Weekly, 2014
  +4 more sources

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study

Annals of Oncology, 2008
C Butts, M Navarro, S Gollins
exaly  

Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells

British Journal of Cancer, 2004
Diego Arango, Qian Shi, John M Mariadason   +2 more
exaly  

Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer

Annals of Oncology, 2015
C Hamada
exaly  

Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients

Annals of Oncology, 2004
E Mitry, V Boige, J F Seitz
exaly  

Preparation, characterisation and antitumour activity of β-, γ- and HP-β-cyclodextrin inclusion complexes of oxaliplatin

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2016
Jianqiang Zhang, Jun Lin
exaly  

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

Annals of Oncology, 2004
C Tournigand, F Selle, F Paye
exaly